- Statin Use After Diagnosis of Hepatocellular Carcinoma Is Associated With Decreased Mortality
Aaron P. Thrift et al, 2019, Clinical Gastroenterology and Hepatology CrossRef - Clinical outcomes of patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective study of routine clinical practice in multi-institutions
Sae Hwan Lee et al, 2015, BMC Cancer CrossRef - Proanthocyanidins extracted from grape seeds inhibit the growth of hepatocellular carcinoma cells and induce apoptosis through the MAPK/AKT pathway
Wancai Zheng et al, 2022, Food Bioscience CrossRef - Comparison between Atezolizumab Plus Bevacizumab and Lenvatinib for Hepatocellular Carcinoma in Patients with Child-Pugh Class B in Real-World Clinical Settings
Hideko Ohama et al, 2023, Oncology CrossRef - Inhibition effect of miR-577 on hepatocellular carcinoma cell growth via targeting β-catenin
Li-Yan Wang et al, 2015, Asian Pacific Journal of Tropical Medicine CrossRef - Polypyridyl Ruthenium(II) complex-induced mitochondrial membrane potential dissipation activates DNA damage-mediated apoptosis to inhibit liver cancer
Yumei Li et al, 2019, European Journal of Medicinal Chemistry CrossRef - Portal vein tumor thrombus in advanced hepatocellular carcinoma: A case report
XIANLI CHEN et al, 2015, Oncology Letters CrossRef - OSU-2S/Sorafenib Synergistic Antitumor Combination against Hepatocellular Carcinoma: The Role of PKCδ/p53
Hany A. Omar et al, 2016, Frontiers in Pharmacology CrossRef - CheckMate 040 cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis
Masatoshi Kudo et al, 2021, Journal of Hepatology CrossRef - Adoption of Sorafenib for the Treatment of Advanced-Stage Hepatocellular Carcinoma in Oncology Practices in the United States
Helen M. Parsons et al, 2017, Liver Cancer CrossRef - Pylorus-preserving pancreaticoduodenectomy versus standard pancreaticoduodenectomy in the treatment of duodenal papilla carcinoma
Rui Zhao et al, 2018, Oncology Letters CrossRef - Lenvatinib in patients with unresectable hepatocellular carcinoma who progressed to Child-Pugh B liver function
Jasmine Huynh et al, 2022, Therapeutic Advances in Medical Oncology CrossRef - Comparative analysis of current guidelines for the treatment of hepatocellular carcinoma
Francesco Tovoli et al, 2016, Hepatic Oncology CrossRef - Survival and tolerance to sorafenib in Child-Pugh B patients with hepatocellular carcinoma: a prospective study
Cassia Regina Guedes Leal et al, 2018, Investigational New Drugs CrossRef - Parametric response mapping of contrast-enhanced biphasic CT for evaluating tumour viability of hepatocellular carcinoma after TACE
Jan B. Hinrichs et al, 2016, European Radiology CrossRef - Liver stiffness in magnetic resonance elastography is prognostic for sorafenib-treated advanced hepatocellular carcinoma
Bohyun Kim et al, 2021, European Radiology CrossRef - Survival benefit of chemoembolization plus Iodine125 seed implantation in unresectable hepatitis B-related hepatocellular carcinoma with PVTT: a retrospective matched cohort study
Mingsheng Huang et al, 2016, European Radiology CrossRef - Combined Antitumor Effects of Sorafenib and GPC3-CAR T Cells in Mouse Models of Hepatocellular Carcinoma
Xiuqi Wu et al, 2019, Molecular Therapy CrossRef - Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience
Tiago de Castro et al, 2022, Therapeutic Advances in Medical Oncology CrossRef - Effect and safety of sorafenib in patients with intermediate hepatocellular carcinoma who received transarterial chemoembolization: A retrospective comparative study
Xue-Fen Lei et al, 2018, World Journal of Clinical Cases CrossRef - The albumin–bilirubin grade improves hepatic reserve estimation post‐sorafenib failure: implications for drug development
D. J. Pinato et al, 2017, Alimentary Pharmacology & Therapeutics CrossRef